Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner

INTRODUCTION: HIV-infected patients treated with Highly Active Antiretroviral Therapy (HAART) may be predisposed to hypertriglyceridemia, which gives rise to a highly atherogenic lipid profile known as atherogenic dyslipidemia (AD). We propose that genetic variability leaves some HIV-infected patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Echeverría, Patricia, Guardiola, Montse, González, Marta, Carles Vallvé, Joan, Puig, Jordi, Bonjoch, Anna, Clotet, Bonaventura, Ribalta, Josep, Negredo, Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P025
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224864/
https://www.ncbi.nlm.nih.gov/pubmed/25394064
http://dx.doi.org/10.7448/IAS.17.4.19557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224864/
https://www.ncbi.nlm.nih.gov/pubmed/25394064
http://dx.doi.org/10.7448/IAS.17.4.19557

Ejemplares similares